Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...

UK-based drugmaker Advanz Pharma has announced that following the grant of a temporary suspension, as announced on last month ...

Kronos Bio has announced a major restructuring, including significant workforce reductions, as it grapples with clinical and ...

Japanese drugmaker Eisai today that the humanized antisoluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) has been launched in South Korea.

The European Medicines Agency has approved Tevimbra (tislelizumab) in combination with chemotherapy for advanced throat and ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

The US Food and Drug Administration (FDA) has extended the review period for Soleno Therapeutics’ the New Drug Application ...

After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...

The Down syndrome treatment market in the USA is valued at nearly $250 million, with companies like Aelis Farma, AC Immune, ...

The strain of opioid use disorder (OUD), a chronic neurological disorder characterized by the compulsive, repeated use of ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now ...